Frontiers
US$ 20.60
retatrutide gip glp-1 glucagon receptor agonist Science Behind GLP 1 and Agonists for Obesity Research | News & Announcements retatrutide triple hormone receptor agonist
Description
Weight loss treatment changes more than weight
Its a man-made peptide developed by Eli Lilly and Company, and it works by acting on three hormones in the body: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polyp
Not research-grade powder
FUELD GLP-1 Pro supports appetite control, metabolism, and gut health with 1.25B CFU probiotics per serving
Secondary outcomes included time below and above the therapeutic range and INR variability
